What questions should I ask about a Pancreatic Cancer clinical trial

Questions to Ask About a Pancreatic Cancer Clinical Trial

This is an excellent question—asking the right questions helps you make an informed decision about whether a trial is right for you. Here are the key questions organized by category:

About the Trial Itself

According to the NCCN Guidelines for Patients: Pancreatic Cancer, you should ask:

1. What is the purpose of this clinical trial? What problem is it trying to solve, and what makes it different from standard treatment?

2. What stage of testing is this trial in? (Phase 1, 2, 3, or 4?) This tells you how much is already known about safety and effectiveness.

3. How long will I be in the trial? What's the time commitment, and what happens if I want to leave?

4. What treatments are being tested? Are these completely new drugs, new combinations of existing drugs, or existing drugs used in a new way?

5. Has this treatment been used for other types of cancer? This can give you context about what's already known.

About Your Specific Situation

1. Do I meet the eligibility criteria? What are the specific requirements, and why might some patients not qualify?

2. How do my age, overall health, and other medical conditions affect my eligibility? Pancreatic cancer patients often have additional health challenges (like diabetes-related symptoms, malnutrition, or nerve damage), so understanding how these factor in is important.

3. Are there any treatments I've already had that would disqualify me? Some trials have "washout periods"—waiting times after previous treatments—so understanding these requirements matters.

About Safety and Side Effects

1. What are the known side effects of this treatment? Both from the experimental drug AND from any standard chemotherapy included in the trial.

2. How will side effects be managed? What support is available if you experience problems?

3. What safety monitoring will happen? How often will you have blood work, scans, or other tests to watch for problems?

4. What happens if serious side effects occur? Can you stop the trial? Will you still get standard care?

About Effectiveness and Outcomes

1. How will you know if the treatment is working? Will they use scans, blood tests, or other measures? How often will they check?

2. What does "success" look like in this trial? Are they measuring tumor shrinkage, survival time, quality of life, or something else?

3. What are the early results so far, if any? If the trial is already enrolling patients, what have researchers learned?

About Practical Matters

1. What will this cost me? According to Let's Win Pancreatic Cancer, the experimental drug itself is typically covered, BUT you should ask:

   • Will my insurance cover standard care costs and tests?
   • Are there extra clinic visits or lab work I'll need to pay for?
   • Does the trial cover travel expenses or mileage?

2. How often will I need to come to the clinic? Can you do this realistically given your location and health?

3. Will I be able to get other treatment if this doesn't work? Can you leave the trial and pursue other options?

About Your Treatment Options

According to the NCCN Guidelines, also ask:

1. What are my other treatment options besides this trial? Make sure you understand standard care alternatives.

2. Is a clinical trial an option for me? Your doctor should help you understand if you're a good candidate.

3. Are you suggesting options other than what NCCN recommends? If yes, why? This helps you understand the reasoning.

4. How do I get a second opinion? It's completely reasonable to get another expert's perspective on whether this trial makes sense for you.

About Clinical Trials in General

1. What is informed consent, and what will I need to sign? Take time to read the consent form carefully and ask questions before signing.

2. Who monitors this trial for safety? Independent review boards oversee trials to protect participants.

3. Can I talk to other patients who are in this trial? Hearing from others' experiences can be valuable.

Why This Matters for Pancreatic Cancer

According to Let's Win Pancreatic Cancer, pancreatic cancer patients should consider clinical trials early—even as a first treatment option—because:

• Standard treatments alone often aren't enough. Less than 5% of pancreatic cancer patients currently enroll in trials, but experts recommend considering them from day one.
• You get "standard of care plus." If you're in the control group, you still receive the best current treatment. If you're in the treatment group, you get that PLUS something new that science suggests might work better.
• Pancreatic cancer is aggressive. Because outcomes with standard treatment alone are limited, accessing cutting-edge options early can make a real difference.

---

Key Takeaway

Don't wait for your doctor to bring up clinical trials—start the conversation yourself. Write down these questions, bring them to your appointments, and take time to discuss the answers with your healthcare team and trusted family members before making a decision.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.